Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.

@article{Jackson2009PhaseIC,
  title={Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.},
  author={Lisa A. Jackson and Roger Baxter and Keith S. Reisinger and Annette Karsten and Jina Shah and Lisa Bedell and Peter M. Dull},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2009},
  volume={49 1},
  pages={e1-10}
}
BACKGROUND Neisseria meningitidis is an important cause of invasive bacterial infection in the United States, and disease rates are higher for adolescents than for the general population. Quadrivalent meningococcal conjugate vaccine is recommended for routine vaccination of adolescents and high-risk groups. This study compares the safety and immunogenicity of the Novartis Vaccines investigational quadrivalent meningococcal CRM(197) conjugate vaccine, MenACWY-CRM, with the licensed meningococcal… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 37 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 40 references

for prevention of meningococcal diseases

  • Snape, KP Perrett, KJ Ford
  • 2008

Safety and immunogenicity 12 months postvaccination with Novartis Vaccines’ tetravalent glycoconjugate meningococcal ACWY vaccine in children aged 2–10 years [abstract 191

  • S Black, J Shah, L. Danzig
  • Program and abstracts of the 45th Annual Meeting…
  • 2007
1 Excerpt

Similar Papers

Loading similar papers…